Phillips, K., Milne, R., Rookus, M., Goldgar, D., Friedlander, M., McLachlan, S., . . . Hopper, J. (2012). Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. BioMed Central.
Citación estilo ChicagoPhillips, KA, et al. Association of Tamoxifen Use and Reduced Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers. BioMed Central, 2012.
Cita MLAPhillips, KA, et al. Association of Tamoxifen Use and Reduced Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers. BioMed Central, 2012.
Precaución: Estas citas no son 100% exactas.